Cytomegalovirus (CMV) infection in renal transplant patients managed with early pre-emptive treatment

被引：0
|
作者：
Anyu, Anawinla Ta [1 ]
Lucey, Mary [1 ]
Jones, Gareth [2 ]
Harber, Mark [2 ]
Hart, Jennifer [1 ]
Irish, Dianne [1 ]
Haque, Tanzina [1 ]
机构：
[1] Royal Free Hosp, Dept Clin Virol, London, England
[2] Royal Free Hosp, UCL Dept Renal Med, London, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
10.1093/ndt/gfae069.1705
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
1569
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cytomegalovirus (CMV) infection in renal transplant patients managed with early pre-emptive treatment
    Anyu, Anawinla Ta
    Lucey, Mary
    Jones, Gareth
    Harber, Mark
    Hart, Jennifer
    Irish, Dianne
    Haque, Tanzina
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2692 - I2692
  • [2] Cidofovir as pre-emptive therapy of cytomegalovirus (CMV) infection after allogeneic transplant.
    Tagliaferri, E
    Soligo, D
    Deliliers, DL
    Della Volpe, A
    Annaloro, C
    Cardone, R
    Deliliers, GL
    BONE MARROW TRANSPLANTATION, 1999, 23 : S67 - S67
  • [3] Pre-emptive CMV therapy versus universal CMV prophylaxis in renal transplant recipients
    Rebecca Kelsey
    Nature Reviews Nephrology, 2012, 8 (11) : 614 - 614
  • [4] Prophylactic and pre-emptive treatment of CMV post renal transplantation
    Hughes, P
    Howden, B
    Tomlinson, D
    Ierino, F
    IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (02): : A10 - A10
  • [5] Prophylaxis Versus Pre-Emptive Treatment for Prevention of Cytomegalovirus Infection in CMV-Seropositive Orthotopic Liver-Transplant Recipients
    Mengelle, Catherine
    Rostaing, Lionel
    Weclawiak, Hugo
    Rossignol, Cecile
    Kamar, Nassim
    Izopet, Jacques
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (05) : 836 - 844
  • [6] A QUANTITATIVE ANALYSIS OF CMV INFECTION IN SOLID-ORGAN TRANSPLANT RECIPIENTS MANAGED EXCLUSIVELY ON PRE-EMPTIVE THERAPY
    Atabani, Sowsan F.
    Atkinson, Claire
    Aldridge, Robert W.
    Smith, Colette
    Harber, Mark
    Thornbun, Douglas
    Rolando, Nancy
    Emery, Vincent C.
    Griffiths, Paul D.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 175 - 175
  • [7] Cytomegalovirus (CMV) infection in patients treated with alemtuzumab and other non-transplant therapies - A manageable complication with early detection by pre-emptive screening.
    Sah, A
    Moreton, P
    Klapper, PE
    Hale, AD
    Hillmen, P
    BLOOD, 2003, 102 (11) : 109A - 110A
  • [8] Economic Burden of Cytomegalovirus infection in CMV-Seropositive Hematopoietic Stem Cell Transplant Recipients Managed with Pre-Emptive Therapy: A Single Center Experience
    Fang, Jiaqi
    Zavras, Phaedon D.
    Su, Yiqi
    Raval, Amit
    Tang, Yuexin
    Perales, Miguel
    Papanicolaou, Genovefa A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S340 - S341
  • [9] Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection
    Jesus BenMarzouk-Hidalgo, Omar
    Cordero, Elisa
    Martin-Pena, Almudena
    Garcia-Prado, Elena
    Angel Gentil, Miguel
    Angel Gomez-Bravo, Miguel
    Barrera-Pulido, Lydia
    Miguel Cisneros, Jose
    Perez-Romero, Pilar
    ANTIVIRAL THERAPY, 2009, 14 (05) : 641 - 647
  • [10] Prophylactic and pre-emptive therapy for cytomegalovirus infection in kidney transplant patients using oral valganciclovir
    Guirado, L.
    Rabella, N.
    Diaz, J. M.
    Facundo, C.
    Maderuelo, A.
    Margall, N.
    Silva, I.
    Garcia-Maset, R.
    Calabia, J.
    Gimenez, I.
    Garra, N.
    Sola, R.
    Ballarin, J. A.
    NEFROLOGIA, 2008, 28 (03): : 293 - 300
12345